November 4, 2022
Landmark EMPA-KIDNEY Trial Showed Significant Benefit of Jardiance® in Reducing Kidney Disease Progression or Cardiovascular Death by 28% vs. Placebo in People With Chronic Kidney Disease
May 15, 2022
Boehringer Ingelheim’s Latest Investigational Treatment Slowed Lung Function Decline in People Living with Idiopathic Pulmonary Fibrosis
April 21, 2022
Boehringer Ingelheim Launches RenuTend™: a New Stem Cell Therapy to Improve the Healing of Tendon and Suspensory Ligament Injuries in Horses
No current content.